GHB

September 10, 2007

Product: Gamma-hydroxybutyrate (GHB).
Street names: Fantasy, grievous bodily harm (GBH), liquid ecstasy, liquid E, G.
Symptoms: Drowsiness, induced sleep, nausea, reduced inhibitions, dizziness, headache, increased sociability, initial euphoria leading to confusion and agitation.
Potential problems: Extreme drowsiness, loss of consciousness, hallucinations, difficulty focussing eyes, vomiting, impaired movement and speech, reduces muscle tone, disorientation, convulsions/seizures, coma, respiratory distress, slowed heart rate, lowered blood pressure, amnesia, death. Can be addictive with prolonged use.

Source - http://www.drugs.health.gov.au

Ketamine

September 10, 2007
Product: ketamine hydrochloride.
Street names: Green, K, super K, special K, Vitamin K.
Symptoms: Altered perception, disorientation, drowsiness, hallucinations, numbness, strange muscle movements, nausea, vomiting.
Potential problems: Accidents from lack of coordination, quick development of tolerance, psychological dependence, psychosis, flashbacks, loss of memory, attention and vision impairment. As ketamine is an anaesthetic, when used with depressant drugs such as alcohol, heroin or tranquilizers, it can be particularly harmful as it has the potential to shut the body down causing vital organs such as the lungs or heart to stop functioning.

Source - http://www.drugs.health.gov.au

Hallucinogens

September 10, 2007

Product: LSD (lysergic acid diethylamide), Psilocybin.
Street names: LSD – acid, trips, wedges, windowpane, blotter, microdot. Psilocybin – mushies, blue meanies, magic mushrooms, gold tops, datura, angel’s trumpet.
Symptoms: Trance-like state, excitation, euphoria, increased pulse rate, insomnia, hallucinations, paranoia.
Potential problems: visual hallucinations may produce anxiety and fear, confusion and lack of coordination can result in greater risk of injury, self-inflicted injury, violent behaviour, paranoia, depression, anxiety, unpredictable flashbacks.

Source - http://www.drugs.health.gov.au

Continued here.

Contents